NCT06391931View on ClinicalTrials.gov

A Multicenter, Open, Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of Cipepofol Injection for General Anesthesia in Pediatric Patients Undergoing Elective Surgery

PHASE3CompletedINTERVENTIONAL

Enrollment

190

Participants

Timeline

Start Date

April 7, 2024

Primary Completion Date

November 6, 2024

Study Completion Date

November 28, 2024

Conditions

Anesthesia

Interventions

DRUG

Cipepofol

0.6±0.2 mg/kg induce + 0.8 mg/kg/h maintain

DRUG

Propofol

3.0 mg/kg induce + 5.0 mg/kg/h maintain

Trial Locations (1)

Unknown

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors

lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY

NCT06391931 - A Multicenter, Open, Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of Cipepofol Injection for General Anesthesia in Pediatric Patients Undergoing Elective Surgery | Biotech Hunter | Biotech Hunter